Concepts (305)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Embolization, Therapeutic | 23 | 2021 | 263 | 2.380 |
Why?
|
| Intracranial Aneurysm | 14 | 2021 | 177 | 2.310 |
Why?
|
| Endovascular Procedures | 16 | 2021 | 288 | 2.070 |
Why?
|
| Intracranial Arteriovenous Malformations | 14 | 2019 | 110 | 1.810 |
Why?
|
| Stents | 17 | 2022 | 409 | 1.760 |
Why?
|
| Cerebral Angiography | 22 | 2019 | 197 | 1.710 |
Why?
|
| Thrombectomy | 7 | 2021 | 188 | 1.530 |
Why?
|
| Magnetic Resonance Angiography | 15 | 2019 | 275 | 1.300 |
Why?
|
| Central Nervous System Vascular Malformations | 6 | 2014 | 33 | 1.230 |
Why?
|
| Brain Ischemia | 8 | 2020 | 401 | 1.210 |
Why?
|
| Stroke | 11 | 2022 | 990 | 1.160 |
Why?
|
| Neurosurgical Procedures | 5 | 2020 | 234 | 1.040 |
Why?
|
| Angiography, Digital Subtraction | 12 | 2018 | 99 | 0.960 |
Why?
|
| Cerebrovascular Circulation | 7 | 2015 | 231 | 0.900 |
Why?
|
| Aneurysm, Ruptured | 5 | 2021 | 54 | 0.900 |
Why?
|
| Infarction, Middle Cerebral Artery | 3 | 2019 | 40 | 0.900 |
Why?
|
| Carotid Artery Diseases | 4 | 2019 | 99 | 0.850 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 2 | 2015 | 142 | 0.830 |
Why?
|
| Postoperative Complications | 8 | 2020 | 2296 | 0.790 |
Why?
|
| Intracranial Embolism | 1 | 2019 | 29 | 0.670 |
Why?
|
| Carotid Artery, Internal, Dissection | 4 | 2011 | 23 | 0.660 |
Why?
|
| Polyvinyls | 4 | 2013 | 17 | 0.630 |
Why?
|
| Carotid Artery, Internal | 5 | 2016 | 69 | 0.620 |
Why?
|
| Carotid Stenosis | 4 | 2022 | 117 | 0.600 |
Why?
|
| Cerebrovascular Disorders | 4 | 2019 | 145 | 0.580 |
Why?
|
| Algorithms | 4 | 2015 | 1896 | 0.550 |
Why?
|
| Subarachnoid Hemorrhage | 4 | 2020 | 141 | 0.540 |
Why?
|
| Arteriovenous Fistula | 5 | 2014 | 53 | 0.530 |
Why?
|
| Neuroimaging | 2 | 2019 | 116 | 0.520 |
Why?
|
| Dimethyl Sulfoxide | 3 | 2013 | 38 | 0.520 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2018 | 98 | 0.510 |
Why?
|
| Humans | 80 | 2022 | 89567 | 0.500 |
Why?
|
| Spinal Cord | 3 | 2014 | 255 | 0.480 |
Why?
|
| Catheterization | 2 | 2018 | 237 | 0.450 |
Why?
|
| Treatment Outcome | 26 | 2022 | 8209 | 0.440 |
Why?
|
| Cranial Sinuses | 3 | 2021 | 15 | 0.430 |
Why?
|
| Female | 48 | 2021 | 46371 | 0.430 |
Why?
|
| Imaging, Three-Dimensional | 6 | 2019 | 599 | 0.420 |
Why?
|
| Cavernous Sinus | 2 | 2011 | 15 | 0.410 |
Why?
|
| Vasospasm, Intracranial | 2 | 2011 | 35 | 0.410 |
Why?
|
| Angiography | 2 | 2012 | 208 | 0.400 |
Why?
|
| Magnetic Resonance Imaging | 14 | 2019 | 3465 | 0.370 |
Why?
|
| Male | 48 | 2021 | 42464 | 0.360 |
Why?
|
| Aged | 27 | 2021 | 19144 | 0.360 |
Why?
|
| Postpartum Period | 1 | 2011 | 148 | 0.360 |
Why?
|
| Retrospective Studies | 23 | 2021 | 9112 | 0.340 |
Why?
|
| Polymethacrylic Acids | 1 | 2009 | 3 | 0.340 |
Why?
|
| Vertebroplasty | 1 | 2009 | 8 | 0.330 |
Why?
|
| Fractures, Compression | 1 | 2009 | 17 | 0.330 |
Why?
|
| Spinal Fractures | 1 | 2009 | 78 | 0.310 |
Why?
|
| Tomography, X-Ray Computed | 13 | 2013 | 2666 | 0.310 |
Why?
|
| Middle Aged | 31 | 2021 | 25996 | 0.300 |
Why?
|
| Adult | 23 | 2021 | 26684 | 0.300 |
Why?
|
| Mass Screening | 1 | 2013 | 644 | 0.300 |
Why?
|
| Spinal Neoplasms | 1 | 2008 | 49 | 0.300 |
Why?
|
| Hemangioma | 1 | 2008 | 64 | 0.300 |
Why?
|
| Computed Tomography Angiography | 3 | 2018 | 147 | 0.290 |
Why?
|
| Sensitivity and Specificity | 10 | 2019 | 2015 | 0.270 |
Why?
|
| Neck | 1 | 2007 | 104 | 0.270 |
Why?
|
| Head | 1 | 2007 | 137 | 0.270 |
Why?
|
| Pulmonary Artery | 1 | 2008 | 320 | 0.270 |
Why?
|
| Hemodynamics | 3 | 2013 | 731 | 0.260 |
Why?
|
| Vertebral Artery | 2 | 2016 | 24 | 0.240 |
Why?
|
| Lumbar Vertebrae | 2 | 2020 | 152 | 0.240 |
Why?
|
| Cerebral Revascularization | 3 | 2014 | 28 | 0.230 |
Why?
|
| Middle Cerebral Artery | 3 | 2016 | 20 | 0.220 |
Why?
|
| Image Enhancement | 5 | 2019 | 565 | 0.220 |
Why?
|
| Reperfusion | 2 | 2020 | 31 | 0.210 |
Why?
|
| Treatment Failure | 2 | 2021 | 278 | 0.210 |
Why?
|
| Cerebral Arteries | 3 | 2013 | 75 | 0.210 |
Why?
|
| Graves Ophthalmopathy | 2 | 2012 | 4 | 0.200 |
Why?
|
| Optic Nerve Diseases | 2 | 2012 | 18 | 0.200 |
Why?
|
| Deception | 1 | 2022 | 20 | 0.200 |
Why?
|
| Blood Flow Velocity | 4 | 2015 | 200 | 0.200 |
Why?
|
| Thoracic Vertebrae | 2 | 2020 | 51 | 0.200 |
Why?
|
| Risk Assessment | 6 | 2022 | 2304 | 0.200 |
Why?
|
| Endarterectomy, Carotid | 1 | 2022 | 74 | 0.190 |
Why?
|
| Embolic Protection Devices | 1 | 2021 | 9 | 0.190 |
Why?
|
| Carotid Arteries | 2 | 2021 | 135 | 0.190 |
Why?
|
| After-Hours Care | 1 | 2021 | 8 | 0.190 |
Why?
|
| Embolism | 1 | 2021 | 32 | 0.190 |
Why?
|
| Spinal Cord Ischemia | 1 | 2020 | 8 | 0.180 |
Why?
|
| Burnout, Professional | 1 | 2022 | 102 | 0.180 |
Why?
|
| Risk Factors | 8 | 2022 | 5523 | 0.180 |
Why?
|
| Basilar Artery | 1 | 2020 | 42 | 0.170 |
Why?
|
| Conservative Treatment | 1 | 2020 | 21 | 0.170 |
Why?
|
| Radiography | 4 | 2013 | 806 | 0.170 |
Why?
|
| Artifacts | 2 | 2012 | 246 | 0.170 |
Why?
|
| Aged, 80 and over | 9 | 2021 | 6766 | 0.170 |
Why?
|
| Diagnosis, Differential | 5 | 2012 | 1605 | 0.170 |
Why?
|
| Time-to-Treatment | 1 | 2021 | 120 | 0.170 |
Why?
|
| Computer Graphics | 1 | 2019 | 100 | 0.160 |
Why?
|
| Neutrophils | 1 | 2020 | 311 | 0.160 |
Why?
|
| Regional Blood Flow | 1 | 2019 | 198 | 0.160 |
Why?
|
| Observer Variation | 3 | 2015 | 613 | 0.160 |
Why?
|
| Cohort Studies | 5 | 2019 | 2878 | 0.160 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2021 | 227 | 0.150 |
Why?
|
| Vascular Closure Devices | 1 | 2018 | 3 | 0.150 |
Why?
|
| Microsurgery | 1 | 2019 | 90 | 0.150 |
Why?
|
| Lymphocytes | 1 | 2020 | 468 | 0.150 |
Why?
|
| Spinal Diseases | 2 | 2020 | 44 | 0.150 |
Why?
|
| Angioplasty, Balloon | 2 | 2009 | 96 | 0.150 |
Why?
|
| Calcinosis | 1 | 2019 | 231 | 0.150 |
Why?
|
| Aneurysm, False | 2 | 2016 | 54 | 0.150 |
Why?
|
| Aortic Valve Stenosis | 1 | 2019 | 144 | 0.150 |
Why?
|
| Cerebral Veins | 3 | 2013 | 31 | 0.150 |
Why?
|
| Neuroendoscopy | 1 | 2018 | 18 | 0.150 |
Why?
|
| Catheters | 1 | 2018 | 77 | 0.150 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2019 | 178 | 0.150 |
Why?
|
| Intracranial Hypertension | 2 | 2016 | 58 | 0.150 |
Why?
|
| Incidence | 3 | 2020 | 1598 | 0.150 |
Why?
|
| Aortic Valve | 1 | 2019 | 244 | 0.150 |
Why?
|
| Vascular Surgical Procedures | 2 | 2009 | 149 | 0.150 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2015 | 688 | 0.150 |
Why?
|
| Child | 9 | 2021 | 7214 | 0.150 |
Why?
|
| ROC Curve | 3 | 2015 | 777 | 0.140 |
Why?
|
| Thrombosis | 1 | 2020 | 301 | 0.140 |
Why?
|
| Polymers | 1 | 2018 | 195 | 0.140 |
Why?
|
| Intracranial Hemorrhages | 1 | 2018 | 130 | 0.140 |
Why?
|
| Inpatients | 2 | 2022 | 311 | 0.140 |
Why?
|
| Patient Readmission | 1 | 2021 | 353 | 0.140 |
Why?
|
| Contrast Media | 6 | 2015 | 1084 | 0.140 |
Why?
|
| Reproducibility of Results | 8 | 2019 | 2763 | 0.140 |
Why?
|
| Prevalence | 3 | 2021 | 1247 | 0.140 |
Why?
|
| Superior Sagittal Sinus | 1 | 2016 | 2 | 0.130 |
Why?
|
| Mechanical Thrombolysis | 1 | 2016 | 16 | 0.130 |
Why?
|
| Radiation Exposure | 1 | 2016 | 25 | 0.130 |
Why?
|
| Surgical Instruments | 1 | 2015 | 57 | 0.120 |
Why?
|
| Radiation Dosage | 1 | 2016 | 226 | 0.120 |
Why?
|
| Oculomotor Muscles | 2 | 2012 | 30 | 0.120 |
Why?
|
| Physicians | 1 | 2022 | 691 | 0.120 |
Why?
|
| Recurrence | 2 | 2016 | 1143 | 0.120 |
Why?
|
| Hospital Costs | 1 | 2015 | 109 | 0.120 |
Why?
|
| Thrombolytic Therapy | 2 | 2021 | 232 | 0.120 |
Why?
|
| Encephalitis, Varicella Zoster | 1 | 2014 | 6 | 0.120 |
Why?
|
| Emergencies | 2 | 2021 | 122 | 0.120 |
Why?
|
| Capillary Permeability | 1 | 2015 | 132 | 0.120 |
Why?
|
| Herpesvirus 3, Human | 1 | 2014 | 40 | 0.120 |
Why?
|
| Equipment Design | 2 | 2018 | 420 | 0.110 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2014 | 63 | 0.110 |
Why?
|
| Patient Selection | 2 | 2021 | 677 | 0.110 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2013 | 18 | 0.110 |
Why?
|
| Fistula | 1 | 2013 | 42 | 0.110 |
Why?
|
| Gadolinium | 1 | 2013 | 103 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2019 | 1254 | 0.100 |
Why?
|
| Spine | 2 | 2013 | 102 | 0.100 |
Why?
|
| Causality | 1 | 2013 | 80 | 0.100 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2013 | 55 | 0.100 |
Why?
|
| Feasibility Studies | 1 | 2015 | 781 | 0.100 |
Why?
|
| Orbital Diseases | 1 | 2012 | 21 | 0.100 |
Why?
|
| Carotid-Cavernous Sinus Fistula | 1 | 2011 | 4 | 0.100 |
Why?
|
| Astrocytoma | 1 | 2012 | 82 | 0.100 |
Why?
|
| Occipital Bone | 1 | 2011 | 18 | 0.100 |
Why?
|
| Length of Stay | 1 | 2015 | 743 | 0.100 |
Why?
|
| Needs Assessment | 1 | 2013 | 161 | 0.100 |
Why?
|
| Angioplasty | 3 | 2021 | 70 | 0.100 |
Why?
|
| Prospective Studies | 3 | 2016 | 4309 | 0.100 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 345 | 0.100 |
Why?
|
| Vertebral Artery Dissection | 1 | 2011 | 14 | 0.090 |
Why?
|
| Vein of Galen Malformations | 1 | 2010 | 1 | 0.090 |
Why?
|
| Hyperlipidemias | 1 | 2011 | 92 | 0.090 |
Why?
|
| Syndrome | 1 | 2011 | 449 | 0.090 |
Why?
|
| Carotid Artery, External | 1 | 2010 | 8 | 0.090 |
Why?
|
| Cavernous Sinus Thrombosis | 1 | 2010 | 1 | 0.090 |
Why?
|
| Adolescent | 7 | 2021 | 9299 | 0.090 |
Why?
|
| Anticoagulants | 2 | 2011 | 428 | 0.090 |
Why?
|
| Antiviral Agents | 1 | 2014 | 481 | 0.090 |
Why?
|
| Cranial Nerve Diseases | 1 | 2010 | 8 | 0.090 |
Why?
|
| Follow-Up Studies | 5 | 2020 | 3658 | 0.090 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 434 | 0.090 |
Why?
|
| Child, Preschool | 4 | 2021 | 3754 | 0.080 |
Why?
|
| Preoperative Care | 1 | 2012 | 395 | 0.080 |
Why?
|
| Thalamic Diseases | 1 | 2009 | 4 | 0.080 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2011 | 171 | 0.080 |
Why?
|
| Carotid Artery, Common | 1 | 2009 | 28 | 0.080 |
Why?
|
| Back Pain | 1 | 2009 | 42 | 0.080 |
Why?
|
| Carotid Artery Injuries | 1 | 2009 | 22 | 0.080 |
Why?
|
| Moyamoya Disease | 1 | 2009 | 16 | 0.080 |
Why?
|
| Foreign-Body Migration | 1 | 2009 | 39 | 0.080 |
Why?
|
| Comorbidity | 1 | 2013 | 953 | 0.080 |
Why?
|
| Prosthesis Implantation | 1 | 2010 | 126 | 0.080 |
Why?
|
| Subdural Effusion | 1 | 2008 | 2 | 0.080 |
Why?
|
| Intracranial Hypotension | 1 | 2008 | 3 | 0.080 |
Why?
|
| Calcium Channel Blockers | 1 | 2009 | 121 | 0.080 |
Why?
|
| Blood Patch, Epidural | 1 | 2008 | 8 | 0.080 |
Why?
|
| Aortography | 1 | 2008 | 65 | 0.080 |
Why?
|
| Subclavian Artery | 1 | 2008 | 43 | 0.080 |
Why?
|
| Neuronavigation | 1 | 2008 | 22 | 0.080 |
Why?
|
| Pediatrics | 1 | 2012 | 357 | 0.080 |
Why?
|
| Cerebral Hemorrhage | 1 | 2011 | 341 | 0.080 |
Why?
|
| Neck Pain | 1 | 2008 | 18 | 0.080 |
Why?
|
| Radiation Injuries | 1 | 2009 | 162 | 0.070 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2008 | 110 | 0.070 |
Why?
|
| Functional Laterality | 1 | 2008 | 200 | 0.070 |
Why?
|
| Infant | 4 | 2016 | 3174 | 0.070 |
Why?
|
| Nervous System Diseases | 1 | 2009 | 164 | 0.070 |
Why?
|
| Aorta, Thoracic | 1 | 2008 | 168 | 0.070 |
Why?
|
| Hemorrhage | 1 | 2009 | 284 | 0.070 |
Why?
|
| Ischemic Attack, Transient | 1 | 2008 | 182 | 0.070 |
Why?
|
| Databases, Factual | 2 | 2021 | 860 | 0.070 |
Why?
|
| Infant, Newborn | 3 | 2021 | 2487 | 0.070 |
Why?
|
| Neurofibromatosis 2 | 1 | 2005 | 11 | 0.060 |
Why?
|
| Hypertension | 1 | 2011 | 745 | 0.060 |
Why?
|
| Single-Blind Method | 2 | 2016 | 151 | 0.060 |
Why?
|
| Cerebral Infarction | 1 | 2005 | 72 | 0.060 |
Why?
|
| United States | 3 | 2022 | 7041 | 0.060 |
Why?
|
| Time Factors | 3 | 2021 | 5333 | 0.050 |
Why?
|
| Logistic Models | 2 | 2019 | 1214 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2009 | 785 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2011 | 1180 | 0.050 |
Why?
|
| Young Adult | 4 | 2021 | 6362 | 0.050 |
Why?
|
| Fatigue | 1 | 2022 | 172 | 0.050 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2021 | 11 | 0.050 |
Why?
|
| Medical Errors | 1 | 2022 | 115 | 0.050 |
Why?
|
| Brain | 2 | 2009 | 2294 | 0.050 |
Why?
|
| Accidents, Traffic | 1 | 2022 | 98 | 0.050 |
Why?
|
| Sleep Deprivation | 1 | 2022 | 138 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2005 | 589 | 0.050 |
Why?
|
| Hospitals, Community | 1 | 2021 | 32 | 0.050 |
Why?
|
| Combined Modality Therapy | 2 | 2019 | 1705 | 0.050 |
Why?
|
| North America | 1 | 2021 | 184 | 0.050 |
Why?
|
| Infarction | 1 | 2020 | 27 | 0.050 |
Why?
|
| Neurologic Examination | 2 | 2012 | 120 | 0.040 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2021 | 145 | 0.040 |
Why?
|
| Patient Admission | 1 | 2020 | 114 | 0.040 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2021 | 244 | 0.040 |
Why?
|
| Stereotaxic Techniques | 2 | 2009 | 80 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2021 | 392 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2021 | 384 | 0.040 |
Why?
|
| Foreign Bodies | 1 | 2018 | 66 | 0.040 |
Why?
|
| Disease Progression | 2 | 2014 | 1463 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2012 | 1727 | 0.040 |
Why?
|
| Vascular Diseases | 1 | 2018 | 118 | 0.040 |
Why?
|
| Phantoms, Imaging | 1 | 2019 | 453 | 0.030 |
Why?
|
| Chicago | 1 | 2021 | 1430 | 0.030 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2016 | 14 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2016 | 296 | 0.030 |
Why?
|
| Patient Safety | 1 | 2018 | 218 | 0.030 |
Why?
|
| Dominance, Cerebral | 1 | 2015 | 66 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2016 | 218 | 0.030 |
Why?
|
| Radiosurgery | 1 | 2018 | 287 | 0.030 |
Why?
|
| Microcirculation | 1 | 2015 | 104 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2019 | 1862 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 714 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2022 | 2641 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2016 | 251 | 0.030 |
Why?
|
| Shear Strength | 1 | 2013 | 18 | 0.030 |
Why?
|
| Herpes Zoster | 1 | 2014 | 79 | 0.030 |
Why?
|
| Biomarkers | 1 | 2020 | 1768 | 0.030 |
Why?
|
| Aneurysm | 1 | 2013 | 60 | 0.030 |
Why?
|
| Models, Cardiovascular | 1 | 2013 | 107 | 0.030 |
Why?
|
| Muscle Weakness | 1 | 2013 | 61 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2013 | 253 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2012 | 63 | 0.030 |
Why?
|
| Temporal Lobe | 1 | 2013 | 176 | 0.030 |
Why?
|
| Illinois | 1 | 2014 | 484 | 0.030 |
Why?
|
| Magnetic Fields | 1 | 2012 | 11 | 0.030 |
Why?
|
| Orbit | 1 | 2012 | 39 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2015 | 870 | 0.020 |
Why?
|
| Acute Disease | 1 | 2014 | 842 | 0.020 |
Why?
|
| Diplopia | 1 | 2011 | 13 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2013 | 293 | 0.020 |
Why?
|
| Dura Mater | 1 | 2011 | 44 | 0.020 |
Why?
|
| Organ Size | 1 | 2012 | 370 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2011 | 223 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2011 | 336 | 0.020 |
Why?
|
| Drainage | 1 | 2011 | 165 | 0.020 |
Why?
|
| Pain | 1 | 2013 | 399 | 0.020 |
Why?
|
| Temporal Arteries | 1 | 2010 | 9 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2011 | 92 | 0.020 |
Why?
|
| Visual Acuity | 1 | 2011 | 199 | 0.020 |
Why?
|
| Fluorescein Angiography | 1 | 2011 | 96 | 0.020 |
Why?
|
| Survival Rate | 1 | 2014 | 1887 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2011 | 996 | 0.020 |
Why?
|
| Decision Trees | 1 | 2009 | 59 | 0.020 |
Why?
|
| Memory Disorders | 1 | 2009 | 69 | 0.020 |
Why?
|
| Transplants | 1 | 2009 | 41 | 0.020 |
Why?
|
| Myelography | 1 | 2008 | 11 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2009 | 158 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 1723 | 0.020 |
Why?
|
| Hematoma, Subdural | 1 | 2008 | 25 | 0.020 |
Why?
|
| Encephalocele | 1 | 2008 | 26 | 0.020 |
Why?
|
| Age of Onset | 1 | 2009 | 314 | 0.020 |
Why?
|
| Remission, Spontaneous | 1 | 2008 | 52 | 0.020 |
Why?
|
| Age Factors | 1 | 2013 | 1877 | 0.020 |
Why?
|
| Thalamus | 1 | 2009 | 134 | 0.020 |
Why?
|
| Craniotomy | 1 | 2008 | 89 | 0.020 |
Why?
|
| Cervical Vertebrae | 1 | 2008 | 84 | 0.020 |
Why?
|
| Intraoperative Complications | 1 | 2009 | 185 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2009 | 234 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 1850 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2009 | 354 | 0.020 |
Why?
|
| Hemianopsia | 1 | 2005 | 4 | 0.020 |
Why?
|
| Reoperation | 1 | 2008 | 603 | 0.020 |
Why?
|
| Paresis | 1 | 2005 | 16 | 0.020 |
Why?
|
| Aphasia | 1 | 2005 | 15 | 0.020 |
Why?
|
| Neurofibromin 2 | 1 | 2005 | 29 | 0.020 |
Why?
|
| Biopsy | 1 | 2009 | 1183 | 0.020 |
Why?
|
| Head and Neck Neoplasms | 1 | 2012 | 1060 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2008 | 711 | 0.020 |
Why?
|
| Meningioma | 1 | 2005 | 62 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2009 | 476 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2005 | 377 | 0.010 |
Why?
|
| Mutation | 1 | 2005 | 4159 | 0.010 |
Why?
|
| Animals | 1 | 2011 | 27476 | 0.010 |
Why?
|